Home » Topics » BioWorld Science, Dermatologic

BioWorld Science, Dermatologic
RSS

IFX-1 enters phase II study in patients with pyoderma gangrenosum

June 14, 2019

PPC-06 meets both coprimary endpoints in phase IIb study in plaque psoriasis

June 11, 2019

Early signals of clinical activity observed in phase I study of KX2-391 in patients with psoriasis

June 7, 2019

InflaRx reports topline results from phase IIb SHINE study of IFX-1 in hidradenitis suppurativa

June 6, 2019

Clinical study foreseen for Immunic's autoimmune disease candidate IMU-935

June 6, 2019

Pfizer initiates phase II study of PF-06700841 topical cream for atopic dermatitis

June 6, 2019

Aslan reports final results from single-ascending-dose study of ASLAN-004

June 5, 2019

Arcutis begins phase IIa trial of ARQ-151 in atopic dermatitis

June 5, 2019

First patient dosed in B-SIMPLE phase III program of SB-206

June 5, 2019

Dermavant Sciences initiates phase III study of tapinarof for the treatment of plaque psoriasis

June 3, 2019

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...